SimonMed selects AIRS Medical to power the next generation of AI-enhanced MRI across its American network

Independent outpatient imaging provider SimonMed has committed to an enterprise-wide deployment of AIRS Medical’s SwiftMR, an FDA-cleared AI solution for MRI enhancement, across its nationwide network in the USA.

According to AIRS Medical, the decision followed a comprehensive evaluation of leading MRI AI platforms as part of SimonMed’s broader strategy to elevate imaging quality, improve access and deliver a more consistent, patient-centred diagnostic experience at scale. The adoption of SwiftMR reflects a deliberate move to raise the standard across its multi-vendor MRI fleet, improving image clarity, reducing scan times and enhancing overall workflow efficiency.

“AI in imaging has reached a point where it can meaningfully elevate both the quality and accessibility of care, but only if deployed thoughtfully at scale,” said SimonMed MD, chief medical officer and chief innovation officer Dr Sean Raj.

“We rigorously evaluated every major solution in the market and this was a clear decision. We chose AIRS Medical because its technology consistently delivered high quality images, the most reliable performance across diverse scanner environments and the greatest potential to improve the patient experience.”

Picture: Members of the SimonMed team.

Read this report on page 4 of the August 2026 issue of RAD Magazine.